Carperitide is a recombinant form of human atrial natriuretic peptide (hANP), consisting of 28 amino acids. It is mainly used in Japan for the treatment of acute heart failure, as it promotes vasodilation, natriuresis, and diuresis by binding to natriuretic peptide receptors and increasing intracellular cyclic GMP levels. Carperitide helps reduce cardiac preload and afterload, improving hemodynamic stability. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Atriopeptins, Cardionatrin and Hanp. Its PubChem CID is 16129708.
Carperitide
| CAS No | 85637-73-6 |
|---|---|
| Molecular Formula | C127H203N45O39S3 |
| Molecular Weight | 3080.5 g/mol |
| Synonyms | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-19-(3-amino-3-oxopropyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,40-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16-(hydroxymethyl)-22-methyl-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Carperitide is a recombinant form of human atrial natriuretic peptide (hANP), consisting of 28 amino acids.
The listed CAS number is 85637-73-6.
The listed molecular formula is C127H203N45O39S3.
The listed molecular weight is 3080.5 g/mol.
The source lists Atriopeptins, Cardionatrin and Hanp.
It is listed as a commercial API with a peptide origin.